Literature DB >> 2780466

Pizotifen in deafferentation pain.

K Ghose1.   

Abstract

Deafferentation pain is known usually to be resistant to both narcotic and non-narcotic analgesics. Four cases of this condition are reported here in which benefit was obtained with pizotifen, a 5-hydroxytryptamine antagonist. Further controlled clinical studies are required to verify this observation.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2780466      PMCID： PMC2429132          DOI： 10.1136/pgmj.65.760.79

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  9 in total

1.  Increasing doses of naloxone hydrochloride by infusion to treat pain due to the thalamic syndrome.

Authors:  D A Ray; Y M Tai
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

2.  Cardiac arrest after reversal of effects of opiates with naloxone.

Authors:  F M Cuss; C B Colaço; J H Baron
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-04

3.  The central action of pizotifen.

Authors:  E Przegaliński; L Baran; W Palider; J Siwanowicz
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

Review 4.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Trazodone for deafferentation pain. Comparison with amitriptyline.

Authors:  V Ventafridda; A Caraceni; L Saita; C Bonezzi; F De Conno; G Guarise; G Ramella; V Silvani; M Tamburini; F Toscani
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Treatment of post-herpetic neuralgia by prolonged electric stimulation.

Authors:  P W Nathan; P D Wall
Journal:  Br Med J       Date:  1974-09-14

7.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain.

Authors:  S Arnér; B A Meyerson
Journal:  Pain       Date:  1988-04       Impact factor: 6.961

8.  The effect of an antiserotonin agent pizotifen on platelet aggregability in migraine patients.

Authors:  S Mazal; E A Rachmilewitz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

9.  Pizotifen once daily in the prophylaxis of migraine: results of a multi-centre general practice study.

Authors:  D Crowder; W P Maclay
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.